NCT03782675

Brief Summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g., bacteria) present at a surgery site during total shoulder arthroplasty surgeries.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 20, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

December 20, 2018

Status Verified

December 1, 2018

Enrollment Period

3 months

First QC Date

December 13, 2018

Last Update Submit

December 19, 2018

Conditions

Keywords

Total shoulder replacementoperating room airsurgical site infectionairborne CFU

Outcome Measures

Primary Outcomes (2)

  • CFU counts

    Inter-arm comparison of CFU counts taken during both the Control arm and ABS arm

    Four months

  • Particle counts

    Inter-arm comparison of particle counts taken during both the Control arm and ABS arm.

    Four months

Study Arms (2)

Control

SHAM COMPARATOR

In the control arm, the ABS device will be placed as usual on the patient, but the airflow will NOT be activated. Only the technician in the room will be aware whether the device the device is turned on or not.

Device: Control

Air Barrier System

EXPERIMENTAL

In the experimental (interventional) arm, the ABS device will be placed as usual on the patient, and the airflow will be activated. Only the technician in the room will be aware whether the device is turned on or not.

Device: Air Barrier System

Interventions

ControlDEVICE

The Air Barrier System will be deployed onto the surgical field, but the airflow will not be activated, so this is a sham control comparator.

Control

The Air Barrier System is a device that uses localized clean air flow to shield a surgery site from ambient airborne microorganisms that are shed into the air from people present in the operating room.

Air Barrier System

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Candidate for total shoulder arthroplasty

You may not qualify if:

  • Prior history of infection
  • Revision surgery
  • Screens positive for MRSA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Stocks GW, Self SD, Thompson B, Adame XA, O'Connor DP. Predicting bacterial populations based on airborne particulates: a study performed in nonlaminar flow operating rooms during joint arthroplasty surgery. Am J Infect Control. 2010 Apr;38(3):199-204. doi: 10.1016/j.ajic.2009.07.006. Epub 2009 Nov 12.

    PMID: 19913327BACKGROUND

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gregory Stocks, MD

    Texas Orthopedic Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2018

First Posted

December 20, 2018

Study Start

February 1, 2019

Primary Completion

May 1, 2019

Study Completion

July 1, 2019

Last Updated

December 20, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share